HUP9800472A2 - Új benzoxazindionszármazékok, eljárás ezek előállítására és e vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Új benzoxazindionszármazékok, eljárás ezek előállítására és e vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP9800472A2 HUP9800472A2 HU9800472A HUP9800472A HUP9800472A2 HU P9800472 A2 HUP9800472 A2 HU P9800472A2 HU 9800472 A HU9800472 A HU 9800472A HU P9800472 A HUP9800472 A HU P9800472A HU P9800472 A2 HUP9800472 A2 HU P9800472A2
- Authority
- HU
- Hungary
- Prior art keywords
- stone
- antibiotics
- derivatives
- compounds according
- general formula
- Prior art date
Links
- UXTZUUVTGMDXNG-UHFFFAOYSA-N 1,2-benzoxazine-3,4-dione Chemical class C1=CC=C2C(=O)C(=O)NOC2=C1 UXTZUUVTGMDXNG-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000003242 anti bacterial agent Substances 0.000 abstract 3
- 229940088710 antibiotic agent Drugs 0.000 abstract 3
- 239000004575 stone Substances 0.000 abstract 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 230000004888 barrier function Effects 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 abstract 1
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- 208000016286 Iron metabolism disease Diseases 0.000 abstract 1
- 241000589516 Pseudomonas Species 0.000 abstract 1
- 239000000589 Siderophore Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002429 hydrazines Chemical class 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
A találmány (I) általánős képletű benzőxazindiőnszármazékőkra éshatóanyagőkkal (pl. antibiőtikűmők) képezett kőnjűgátűmaikravőnatkőzik. A találmány szerinti vegyületek heterőciklikűsan védettkatechől-származékők és gram-negatív baktériűmtörzsek - különösenPseűdőmőnas, E.cőli és Salmőnella törzsek - esetében siderőphőrkénthatékőnyak. A találmány szerinti vegyületek hatóanyagőkkal (pl.antibiőtikűmők) képezett kőnjűgátűmaik főrmájában (mint ,,siderőphőr-antibiőtikűm kőnjűgátűmők") a hatóanyagőt a baktériűmsejtekbekiüríteni képesek, és a hatóanyag antibakteriális hatékőnyságátjavítják, illetve bővítik, részben más beta-laktámőkkal szembenrezisztens baktériűmtörzsek esetében is. Ezenkívül a fenti vegyületekpőtenciális előgyógyszerfőrmaként (pőtenciális prő-drűg főrma)vaskelátőrként a vasanyagcsere zavarain alapűló betegségek esetében isalkalmazhatók. A találmány szerinti vegyületek a gyógyászatikűtatásban, az iparban és mezőgazdaságban nyerhetnek felhasználást. Az(I) általánős képletben R2 jelentése hidrőgénatőm vagy karbőxi-alkil-csőpőrt; R2 jelentése hidrőgénatőm, alkil- vagy fenilcsőpőrt és R3jelentése valamely, aminősavakból, dipeptidekből vagy hidrazőnőkbóllevezethető savcsőpőrt vagy annak hatóanyagőkkal - pl.antibiőtikűmőkkal - képezett kőnjűgátűma. A fenti vegyületek szabadsavak, sóik és könnyen lehasítható észtereik alakjában lehetnek jelen. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19708846A DE19708846A1 (de) | 1997-03-05 | 1997-03-05 | Neue Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9800472D0 HU9800472D0 (en) | 1998-04-28 |
HUP9800472A2 true HUP9800472A2 (hu) | 1999-06-28 |
HUP9800472A3 HUP9800472A3 (en) | 2000-09-28 |
Family
ID=7822233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9800472A HUP9800472A3 (en) | 1997-03-05 | 1998-03-04 | New benzoxazinedion derivatives, process for producing them and pharmaceutical copositions containing them |
Country Status (30)
Country | Link |
---|---|
US (1) | US6013647A (hu) |
EP (1) | EP0863139B1 (hu) |
JP (1) | JPH10316666A (hu) |
KR (1) | KR19980079905A (hu) |
CN (1) | CN1075064C (hu) |
AR (1) | AR010125A1 (hu) |
AT (1) | ATE200080T1 (hu) |
AU (1) | AU737760B2 (hu) |
BR (1) | BR9802894A (hu) |
CA (1) | CA2230965A1 (hu) |
CO (1) | CO4950613A1 (hu) |
CZ (1) | CZ65098A3 (hu) |
DE (2) | DE19708846A1 (hu) |
DK (1) | DK0863139T3 (hu) |
ES (1) | ES2157617T3 (hu) |
GR (1) | GR3035834T3 (hu) |
HK (1) | HK1015763A1 (hu) |
HU (1) | HUP9800472A3 (hu) |
IL (1) | IL123535A (hu) |
NO (1) | NO310657B1 (hu) |
NZ (1) | NZ329883A (hu) |
PE (1) | PE71799A1 (hu) |
PL (1) | PL325142A1 (hu) |
PT (1) | PT863139E (hu) |
RU (1) | RU2184114C2 (hu) |
SI (1) | SI0863139T1 (hu) |
SK (1) | SK28898A3 (hu) |
UA (1) | UA45414C2 (hu) |
UY (1) | UY24915A1 (hu) |
ZA (1) | ZA981847B (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6115157A (en) * | 1997-12-24 | 2000-09-05 | Nortel Networks Corporation | Methods for equalizing WDM systems |
US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
DE10111164A1 (de) * | 2001-03-01 | 2002-09-05 | Gruenenthal Gmbh | Neue substituierte Catecholderivate abgeleitet von mehrbasischen sekundären Aminosäuren, Verfahren zu ihrer Herstellung und ihre Anwendung |
US7595073B2 (en) * | 2003-02-28 | 2009-09-29 | Kraft Foods Global Brands Llc | Use of siderophores and organic acids to retard lipid oxidation |
US20040186087A1 (en) * | 2003-03-20 | 2004-09-23 | Ceramoptec Industries, Inc. | Siderophore conjugates of photoactive dyes for photodynamic therapy |
CN101180298B (zh) * | 2005-05-25 | 2011-04-27 | 埃科特莱茵药品有限公司 | 抗生素衍生物 |
TWI603962B (zh) | 2016-09-10 | 2017-11-01 | 國立清華大學 | 含硫噁嗪化合物及其合成方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3047573A (en) * | 1962-07-31 | N-alkylamido substituted | ||
FR831710A (fr) * | 1937-02-02 | 1938-09-13 | Procédé de fabrication de fermetures à tirette, à partir de matière non métallique | |
DE1147583B (de) * | 1959-07-01 | 1963-04-25 | Nippon Shinyaku Co Ltd | Verfahren zur Herstellung von 2, 4-Dioxo-dihydro-1, 3-benzoxazinyl-(3)-essigsaeure-dialkylamiden |
GB878603A (en) * | 1959-07-01 | 1961-10-04 | Nippon Shinyaku Co Ltd | Salicyclic acid derivatives |
US4338439A (en) * | 1976-08-26 | 1982-07-06 | Eli Lilly And Company | 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins |
US4338436A (en) * | 1976-08-26 | 1982-07-06 | Eli Lilly And Company | 7-[2-[(Substituted benzoyl)amino]acetamido]cephalosporins |
US4319028A (en) * | 1976-08-26 | 1982-03-09 | Eli Lilly And Company | 7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins |
GB8811055D0 (en) * | 1988-05-10 | 1988-06-15 | Ici Plc | Antibiotic compounds |
JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
AU644008B2 (en) * | 1990-08-10 | 1993-12-02 | Sumitomo Pharmaceuticals Company, Limited | Beta-lactam compounds, and their production and use |
DE4102234A1 (de) * | 1991-01-23 | 1992-07-30 | Dresden Arzneimittel | Neue (alpha)-aminochinolinoyl-(3)-penicilline, verfahren zu deren herstellung und diese enthaltende antibakterielle mittel |
IT1256023B (it) * | 1992-06-10 | 1995-11-20 | Italfarmaco Spa | Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare |
DE19654920A1 (de) * | 1996-06-26 | 1998-01-08 | Gruenenthal Gmbh | Neue synthetische Catecholderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
-
1997
- 1997-03-05 DE DE19708846A patent/DE19708846A1/de not_active Withdrawn
-
1998
- 1998-02-11 DK DK98102312T patent/DK0863139T3/da active
- 1998-02-11 SI SI9830019T patent/SI0863139T1/xx unknown
- 1998-02-11 AT AT98102312T patent/ATE200080T1/de not_active IP Right Cessation
- 1998-02-11 DE DE59800568T patent/DE59800568D1/de not_active Expired - Fee Related
- 1998-02-11 ES ES98102312T patent/ES2157617T3/es not_active Expired - Lifetime
- 1998-02-11 EP EP98102312A patent/EP0863139B1/de not_active Expired - Lifetime
- 1998-02-11 PT PT98102312T patent/PT863139E/pt unknown
- 1998-03-02 CN CN98107749A patent/CN1075064C/zh not_active Expired - Fee Related
- 1998-03-03 NZ NZ329883A patent/NZ329883A/en unknown
- 1998-03-03 CA CA002230965A patent/CA2230965A1/en not_active Abandoned
- 1998-03-03 UY UY24915A patent/UY24915A1/es unknown
- 1998-03-03 UA UA98031095A patent/UA45414C2/uk unknown
- 1998-03-04 AR ARP980100970A patent/AR010125A1/es not_active Application Discontinuation
- 1998-03-04 AU AU56455/98A patent/AU737760B2/en not_active Ceased
- 1998-03-04 HU HU9800472A patent/HUP9800472A3/hu unknown
- 1998-03-04 PE PE1998000152A patent/PE71799A1/es not_active Application Discontinuation
- 1998-03-04 ZA ZA981847A patent/ZA981847B/xx unknown
- 1998-03-04 PL PL98325142A patent/PL325142A1/xx unknown
- 1998-03-04 CO CO98011756A patent/CO4950613A1/es unknown
- 1998-03-04 RU RU98104414/04A patent/RU2184114C2/ru not_active IP Right Cessation
- 1998-03-04 IL IL12353598A patent/IL123535A/xx active IP Right Grant
- 1998-03-04 SK SK288-98A patent/SK28898A3/sk unknown
- 1998-03-04 JP JP10052425A patent/JPH10316666A/ja not_active Withdrawn
- 1998-03-04 CZ CZ98650A patent/CZ65098A3/cs unknown
- 1998-03-04 NO NO19980929A patent/NO310657B1/no not_active IP Right Cessation
- 1998-03-05 KR KR1019980007193A patent/KR19980079905A/ko not_active Application Discontinuation
- 1998-03-05 BR BR9802894A patent/BR9802894A/pt not_active IP Right Cessation
- 1998-03-05 US US09/035,344 patent/US6013647A/en not_active Expired - Fee Related
-
1999
- 1999-02-15 HK HK99100650A patent/HK1015763A1/xx not_active IP Right Cessation
-
2001
- 2001-05-07 GR GR20010400682T patent/GR3035834T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0401431A2 (hu) | Cisztein proteáz inhibitorok 2-ciano-4-amino-pirimidin szerkezettel és katepszin K inhibitor hatással, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
ZA918893B (en) | Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,process for their production and pharmaceutical agents containing these derivatives | |
HUP0100186A2 (hu) | Laktám típusú metalloproteináz-gátló vegyületek és az ilyen vegyületeket tartalmazó gyógyászati készítmények | |
NO308792B1 (no) | Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat | |
IT1256345B (it) | Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione | |
HUP9902409A2 (hu) | Cisztein proteáz inhibitorok | |
ES474288A1 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos | |
IE871733L (en) | Amides | |
AU2505297A (en) | Acylated N-hydroxymethyl thalidomide prodrugs having an immunomodulatory effect | |
ES474289A1 (es) | Un procedimiento para la preparacion de derivados del acido 6-(1'-hidroxietil)-7-oxi-1-aza-biciclo(3,2,0)hept-2-en -2- carboxilico-3-sustutuidos | |
HUP9702042A2 (hu) | 1,1,2-trifenil-but-1-én-származékok alkalmazása atherosclerosis kezelésére alkalmas gyógyszerkészítmények előállítására | |
FR2453649A1 (fr) | Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs | |
HUP9802517A2 (hu) | Foszfonsavval helyettesített benzazepinon-N-ecetsav-származékok, eljárás ezek előállítására és az e vegyületeket tartalmazó gyógyászati készítmények | |
AU2736088A (en) | Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation | |
ATE61340T1 (de) | Aminosaeurederivate und deren verfahren zur herstellung. | |
MA26457A1 (fr) | Vinylpyrrolidone-cephalosporines a substituants basiques, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation | |
HUP0002247A2 (hu) | Proteáz inhibitorok | |
Kim et al. | Silanediol-based inhibitor of thermolysin | |
HUP9800472A2 (hu) | Új benzoxazindionszármazékok, eljárás ezek előállítására és e vegyületeket tartalmazó gyógyszerkészítmények | |
HUP9700005A2 (hu) | 2-Ureido-benzamid-származékok és ilyeneket hatóanyagként tartalmazó gyógyszerkészítmények | |
MXPA03000547A (es) | Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares. | |
HUP9900911A1 (hu) | Gyógyászatilag hatásos zsírsavszármazékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények | |
CA2127067A1 (fr) | Derives d'acide phosphonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
MX9708735A (es) | Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos. | |
HUP0105116A2 (hu) | 2,3-0-Izopropilidén-monoszacharid-származékok, mint sejtadhézió-gátlók és az ezeket tartalmazó gyógyászati készítmények, eljárás a vegyületek előállítására |